Newleos Therapeutics CEO David Donabedian Recognized by Goldman Sachs as One of the Most Exceptional Entrepreneurs at the 2025 Builders and Innovators Summit October 16, 2025
Crystalys lands $205M to bring gout drug first marketed in Japan to the US and Europe September 30, 2025
Newleos Therapeutics Announces Poster Presentation to be Featured at the 2025 World Congress of Biological Psychiatry September 11, 2025
Newleos Therapeutics Announces Poster Presentation to beFeatured at the 2025 World Congress of BiologicalPsychiatry September 9, 2025
Newleos Therapeutics Appoints Stephen Brannan to Board of Directors and Announces NTX-1955 Clinical Progress in Generalized Anxiety Disorder July 24, 2025
